Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tune Therapeutics
Biotech
Sage CMO steps down amid pipeline struggles—Chutes & Ladders
Sage CMO steps down amid pipeline struggles. Former NIH Director Collins retires from agency. Rapport ropes in industry vet as CMO.
Darren Incorvaia
,
Zoey Becker
Mar 7, 2025 8:30am
Tune Tx's $175M series B to fund epigenetic HBV therapy's trials
Jan 13, 2025 8:23am
Tune’s HBV therapy hits the right notes in cells and mice
Dec 7, 2023 2:05pm
ASGCT 2023: New preclinical updates from Tessera, Tune and more
May 23, 2023 10:00am
Music to its ears: Tune bags $40M to alter gene expression
Dec 2, 2021 6:00am